Afsaneh Azadeh
CIK 1414500 · View on SEC EDGAR ↗
First SEC filing: Feb. 22, 2008 · Latest: Feb. 22, 2008
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Oct. 10, 2007 | ALGN | P | 30,000 | — | — | 30,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 20, 2008 | ALGN | Restricted Stock Unit | Common Stock (7,500) | — | — | 7,500 | Acquired |
| Feb. 20, 2008 | ALGN | Restricted Stock Unit | Common Stock (3,000) | — | — | 3,000 | Acquired |
| Feb. 20, 2008 | ALGN | Right to buy (Common Stock) | Common Stock (25,000) | $13.00 | Feb. 20, 2018 | 25,000 | Acquired |
| Feb. 20, 2008 | ALGN | Right to Buy (Common Stock) | Common Stock (10,000) | $13.00 | Feb. 20, 2018 | 10,000 | Acquired |
| Oct. 10, 2007 | ALGN | Right to Buy (Common Stock) | Common Stock (90,000) | $28.21 | Oct. 10, 2017 | 90,000 | Acquired |
| Oct. 10, 2007 | ALGN | Restricted Stock Unit | Common Stock (30,000) | — | — | 30,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2008 | $155,591 | — | $280,557 | $650,519 | — | — | $500,485 | $1,587,151 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.